Sandbox/AL: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 9: Line 9:
! style="background: #4479BA; color:#FFF;  width: 350px;" | Treatment
! style="background: #4479BA; color:#FFF;  width: 350px;" | Treatment
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | [[Pneumocystis Pneumonia]]
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | [[Pneumocystis pneumonia|Pneumocystis Pneumonia]]
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
*Caused by the fungus ''Pneumocystis jirovecii''.  
*Caused by the fungus ''Pneumocystis jirovecii''.  
Line 16: Line 16:
| style="padding: 5px 5px; background: #F5F5F5;" |Subacute onset of progressive dyspnea, fever, nonproductive cough, and chest discomfort that worsens within days to weeks. Tachypnea, tachycardia, and diffuse dry rales are found in the physical examination.   
| style="padding: 5px 5px; background: #F5F5F5;" |Subacute onset of progressive dyspnea, fever, nonproductive cough, and chest discomfort that worsens within days to weeks. Tachypnea, tachycardia, and diffuse dry rales are found in the physical examination.   
| style="padding: 5px 5px; background: #F5F5F5;" | Clinical presentation, blood tests, or chest x-rays are not pathognomonic for PCP.
| style="padding: 5px 5px; background: #F5F5F5;" | Clinical presentation, blood tests, or chest x-rays are not pathognomonic for PCP.
| style="padding: 5px 5px; background: #F5F5F5;" | Start TMP-SMX prophylaxys when CD4+ <200 cells/µL or history of oropharyngeal candidiasis.  <br> Discontinue prohylaxys when  CD4+ is >200 cells/µL for >3 month.
| style="padding: 5px 5px; background: #F5F5F5;" | Start TMP-SMX prophylaxis when CD4+ <200 cells/µL or history of oropharyngeal candidiasis.  <br> Discontinue prophylaxis when  CD4+ is >200 cells/µL for >3 month.
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
*TMP-SMX  
*TMP-SMX  
Line 23: Line 23:
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | [[Toxoplasma gondii]] Encephalitis
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | [[Toxoplasma gondii]] Encephalitis
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
* Caused by the protozoan ''Toxoplasma gondii''
| style="padding: 5px 5px; background: #F5F5F5;" |
* The greatest risk of disease occurs among patients with a CD4+ <50 cells/µL
| style="padding: 5px 5px; background: #F5F5F5;" |
* Primary infection occurs after eating undercooked meat containing tissue cysts or ingesting oocysts that have been shed in cat feces and have sporulated in the environment
| style="padding: 5px 5px; background: #F5F5F5;" | Focal encephalitis with headache, confusion, or motor weakness and fever
| style="padding: 5px 5px; background: #F5F5F5;" | Diagnosis is done with IgG antibodies.  CT scan or MRI of the brain will typically show multiple contrast-enhancing lesions, often with associated edema.  Definite diagnosis requires a brain biopsy.
| style="padding: 5px 5px; background: #F5F5F5;" |Start TMP-SMX prophylaxis when CD4+ <100 cells/µL <br> Discontinue prophylaxis when  CD4+ is >200 cells/µL for >3 month.
| style="padding: 5px 5px; background: #F5F5F5;" | Administer:
* [[Pyrimethamine]], PLUS 
* [[Sulfadiazine]], PLUS
* [[Leucovorin]]
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | Cryptosporidiosis  
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | Cryptosporidiosis  

Revision as of 20:20, 14 October 2014

Disease Description Clinical Findings Diagnosis Prophylaxis Treatment
Pneumocystis Pneumonia
  • Caused by the fungus Pneumocystis jirovecii.
  • 90% of cases occurred among patients with CD4+ <200
  • Incidence among HIV patients: 2-3 cases per 100 person-year
Subacute onset of progressive dyspnea, fever, nonproductive cough, and chest discomfort that worsens within days to weeks. Tachypnea, tachycardia, and diffuse dry rales are found in the physical examination. Clinical presentation, blood tests, or chest x-rays are not pathognomonic for PCP. Start TMP-SMX prophylaxis when CD4+ <200 cells/µL or history of oropharyngeal candidiasis.
Discontinue prophylaxis when CD4+ is >200 cells/µL for >3 month.
  • TMP-SMX
  • Administer adjunctive corticosteroids in patients with pO2 <70 mm Hg or arterial-alveolar O2 gradient >35 mm Hg
Toxoplasma gondii Encephalitis
  • Caused by the protozoan Toxoplasma gondii
  • The greatest risk of disease occurs among patients with a CD4+ <50 cells/µL
  • Primary infection occurs after eating undercooked meat containing tissue cysts or ingesting oocysts that have been shed in cat feces and have sporulated in the environment
Focal encephalitis with headache, confusion, or motor weakness and fever Diagnosis is done with IgG antibodies. CT scan or MRI of the brain will typically show multiple contrast-enhancing lesions, often with associated edema. Definite diagnosis requires a brain biopsy. Start TMP-SMX prophylaxis when CD4+ <100 cells/µL
Discontinue prophylaxis when CD4+ is >200 cells/µL for >3 month.
Administer:
Cryptosporidiosis
Microsporidiosis
Mycobacterium tuberculosis
Table adapted from Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents [1]
  1. "Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents".